These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 15888496

  • 1. Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.
    Opitz CF, Wensel R, Winkler J, Halank M, Bruch L, Kleber FX, Höffken G, Anker SD, Negassa A, Felix SB, Hetzer R, Ewert R.
    Eur Heart J; 2005 Sep; 26(18):1895-902. PubMed ID: 15888496
    [Abstract] [Full Text] [Related]

  • 2. Long-term therapy with inhaled iloprost in patients with pulmonary hypertension.
    Olschewski H, Hoeper MM, Behr J, Ewert R, Meyer A, Borst MM, Winkler J, Pfeifer M, Wilkens H, Ghofrani HA, Nikkho S, Seeger W.
    Respir Med; 2010 May; 104(5):731-40. PubMed ID: 20153158
    [Abstract] [Full Text] [Related]

  • 3. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
    Krug S, Hammerschmidt S, Pankau H, Wirtz H, Seyfarth HJ.
    Respiration; 2008 May; 76(2):154-9. PubMed ID: 17804899
    [Abstract] [Full Text] [Related]

  • 4. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.
    Kramm T, Eberle B, Guth S, Mayer E.
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):882-8. PubMed ID: 16242948
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.
    Melnick L, Barst RJ, Rowan CA, Kerstein D, Rosenzweig EB.
    Am J Cardiol; 2010 May 15; 105(10):1485-9. PubMed ID: 20451700
    [Abstract] [Full Text] [Related]

  • 6. Inhaled iloprost for severe pulmonary hypertension.
    Olschewski H, Simonneau G, Galiè N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W, Aerosolized Iloprost Randomized Study Group.
    N Engl J Med; 2002 Aug 01; 347(5):322-9. PubMed ID: 12151469
    [Abstract] [Full Text] [Related]

  • 7. Inhaled iloprost as a long-term additional therapy to oral sildenafil in severe idiopathic pulmonary arterial hypertension.
    Onen ZP, Akkoca Yildiz O, Eriş Gülbay B, Karabiyikoğlu G.
    Tuberk Toraks; 2006 Aug 01; 54(2):177-81. PubMed ID: 16924576
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The acute effects of inhaled iloprost on hemodynamics and oxygenation in chronic thromboembolic pulmonary hypertension].
    Luo L, Yang YH, Cui N, Xie WM, Zhai ZG, Ma ZH, Wang C.
    Zhonghua Yi Xue Za Zhi; 2009 Aug 11; 89(30):2103-5. PubMed ID: 20058612
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery.
    Yurtseven N, Karaca P, Uysal G, Ozkul V, Cimen S, Tuygun AK, Yuksek A, Canik S.
    Ann Thorac Cardiovasc Surg; 2006 Oct 11; 12(5):319-23. PubMed ID: 17095973
    [Abstract] [Full Text] [Related]

  • 13. Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.
    Ewert R, Opitz CF, Wensel R, Winkler J, Halank M, Felix SB.
    Clin Res Cardiol; 2007 Apr 11; 96(4):211-7. PubMed ID: 17294349
    [Abstract] [Full Text] [Related]

  • 14. Long-term inhaled iloprost use in children with pulmonary arterial hypertension.
    Alehan D, Yıldırım I, Sahin M, Ozkutlu S, Ozer S, Karagöz T.
    Cardiol Young; 2012 Aug 11; 22(4):396-403. PubMed ID: 22067137
    [Abstract] [Full Text] [Related]

  • 15. Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension.
    Hoeper MM, Leuchte H, Halank M, Wilkens H, Meyer FJ, Seyfarth HJ, Wensel R, Ripken F, Bremer H, Kluge S, Hoeffken G, Behr J.
    Eur Respir J; 2006 Oct 11; 28(4):691-4. PubMed ID: 17012628
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.
    Melgosa MT, Ricci GL, García-Pagan JC, Blanco I, Escribano P, Abraldes JG, Roca J, Bosch J, Barberà JA.
    Liver Transpl; 2010 Mar 11; 16(3):348-56. PubMed ID: 20209595
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcome with intravenous iloprost in pulmonary arterial hypertension.
    Hoeper MM, Gall H, Seyfarth HJ, Halank M, Ghofrani HA, Winkler J, Golpon H, Olsson KM, Nickel N, Opitz C, Ewert R.
    Eur Respir J; 2009 Jul 11; 34(1):132-7. PubMed ID: 19251782
    [Abstract] [Full Text] [Related]

  • 19. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
    Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuermeyer A, Spiekerkoetter E, Niedermeyer J, Hamm M, Fabel H.
    N Engl J Med; 2000 Jun 22; 342(25):1866-70. PubMed ID: 10861321
    [Abstract] [Full Text] [Related]

  • 20. Acute resynchronization with inhaled iloprost in a pregnant woman with idiopathic pulmonary artery hypertension.
    Cotrim C, Simões O, Loureiro MJ, Cordeiro P, Miranda R, Silva C, Avillez T, Carrageta M.
    Rev Port Cardiol; 2006 May 22; 25(5):529-33. PubMed ID: 16910160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.